Quality assessment for pediatric COVID-19 guidelines_Chinese Journal of Evidence-Based Medicine

Authors：

QIN Jiaxin ¹ , CHEN Tao ¹ , CHE Gang ² , WANG Han ³ , XU Zhifei ⁴ ,  LIU Yali ⁵

1. The First Clinical Medical College of Lanzhou University, Lanzhou 730000, P. R. China;
2. Department of Cardiology, The First People’s Hospital of Jiayuguan City, Jiayuguan 735100, P. R. China;
3. Henan University, Kaifeng 475004, P. R. China;
4. Department of Respiratory, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, National Clinical Research Center for Respiratory Diseases, Beijing 100045, P. R. China;
5. Center for Clinical Epidemiology and Evidence-Based Medicine, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing 100045, P. R. China;

Corresponding author：

LIU Yali, Email: lyl_201006@126.com

Keywords：

Children; COVID-19; Practice guideline; Quality assessment; AGREE Ⅱ

DOI：

10.7507/1672-2531.202112046

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To assess the methodological quality of pediatric COVID-19 guidelines using the AGREE Ⅱ. Methods Domestic and foreign pediatric COVID-19 guidelines from inception to 1^st Oct 2021 were electronically searched in PubMed, CBM, CNKI, VIP, WanFang Data, Medlive, NGC, GIN, and NICE databases and relevant websites. Two researchers independently assessed the methodological quality of the guidelines by using AGREE Ⅱ. Results A total of 21 guidelines were included. The AGREE Ⅱ results revealed that the average scores of included guidelines in 6 domains (scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence) were 62.70%, 36.24%, 20.34%, 50.42%, 22.12% and 53.17%, respectively. Conclusion The methodological quality of pediatric COVID-19 guidelines is poor. Guideline developers should follow the requirements of AGREE Ⅱ in guideline development.

Citation： QIN Jiaxin, CHEN Tao, CHE Gang, WANG Han, XU Zhifei, LIU Yali. Quality assessment for pediatric COVID-19 guidelines. Chinese Journal of Evidence-Based Medicine, 2022, 22(4): 457-462. doi: 10.7507/1672-2531.202112046 Copy

1.	World Health Organization. WHO Coronavirus (COVID-19) Dashboard, 2021-11-12. Available at: https: //covid19. who. int/.
2.	World Health Organization. WHO Coronavirus (COVID-19) Dashboard, 2021-08-08. Available at: https: //covid19. who. int/.
3.	Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med, 2020, 382(17): 1663-1665.
4.	Panda PK, Sharawat IK, Natarajan V, et al. COVID-19 treatment in children: A systematic review and meta-analysis. J Family Med Prim Care, 2021, 10(9): 3292-3302.
5.	Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ: advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18): E839-E842.
6.	Chen Y, Wang C, Shang H, et al. Clinical practice guidelines in China. BMJ, 2018, 360: j5158.
7.	Nuckols TK, Anderson L, Popescu I, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med, 2014, 160(1): 38-47.
8.	Inaba K. The significant of practical guideline in social context. Clin Neurol, 2003, 43(11): 850-851.
9.	Henderson LA, Canna SW, Friedman KG, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol, 2020, 72(11): 1791-1805.
10.	Henderson LA, Canna SW, Friedman KG, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol, 2021, 73(4): e13-e29.
11.	Karimi M, Bozorgi H, Zarei T, et al. Antithrombotic prophylaxis in children and adolescents' patients with SARS-CoV-2 (COVID-19) infection: A practical guidance for clinicians. Acta Biomed, 2020, 91(4): e2020170.
12.	Cattalini M, Taddio A, Bracaglia C, et al. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics. Ital J Pediatr, 2021, 47(1): 24.
13.	Wang L, Shi Y, Xiao T, et al. Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition). Ann Transl Med, 2020, 8(3): 47.
14.	Matava CT, Kovatsis PG, Lee JK, et al. Pediatric airway management in COVID-19 patients: consensus guidelines from the society for pediatric anesthesia's pediatric difficult intubation collaborative and the Canadian pediatric anesthesia society. Anesth Analg, 2020, 131(1): 61-73.
15.	Hennon TR, Penque MD, Abdul-Aziz R, et al. COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) guidelines; a Western New York approach. Prog Pediatr Cardiol, 2020: 101232.
16.	Thompson S, Bohn MK, Mancini N, et al. IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients. Clin Chem Lab Med, 2020, 58(12): 2009-2016.
17.	Wolf J, Abzug MJ, Wattier RL, et al. Initial guidance on use of monoclonal antibody therapy for treatment of coronavirus disease 2019 in children and adolescents. J Pediatric Infect Dis Soc, 2021, 10(5): 629-634.
18.	Edelson DP, Sasson C, Chan PS, et al. Interim guidance for basic and advanced life support in adults, children, and neonates with suspected or confirmed COVID-19: from the emergency cardiovascular care committee and get with the guidelines-resuscitation adult and pediatric task forces of the American Heart Association. Circulation, 2020, 141(25): e933-e943.
19.	Ong GY, Ng BHZ, Mok YH, et al. Interim Singapore guidelines for basic and advanced life support for paediatric patients with suspected or confirmed COVID-19. Singapore Med J, 2021, online ahead of print. Doi: 10.11622/smedj.2021014.
20.	Chiotos K, Hayes M, Kimberlin DW, et al. Multicenter interim guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2. J Pediatric Infect Dis Soc, 2021, 10(1): 34-48.
21.	Bansal N, Azeka E, Neunert C, et al. Multisystem inflammatory syndrome associated with COVID-19 anti-thrombosis guideline of care for children by action. Pediatr Cardiol, 2021, 42(7): 1635-1639.
22.	Liu E, Smyth RL, Luo Z, et al. Rapid advice guidelines for management of children with COVID-19. Ann Transl Med, 2020, 8(10): 617.
23.	曾玫, 柳龚堡. 儿童新型冠状病毒感染/肺炎疑似和确诊病例快速筛查和临床实践指南. 中国循证儿科杂志, 2020, 15(1): 1-4.
24.	陈志敏, 傅君芬, 舒强, 等. 儿童2019冠状病毒病(COVID-19)诊疗指南(第二版). 浙江大学学报(医学版), 2020, 49(2): 139-146.
25.	Dulek DE, Fuhlbrigge RC, Tribble AC, et al. Multidisciplinary guidance regarding the use of immunomodulatory therapies for acute coronavirus disease 2019 in pediatric patients. J Pediatric Infect Dis Soc, 2020, 9(6): 716-737.
26.	DeFazio JR, Kahan A, Fallon EM, et al. Development of pediatric surgical decision-making guidelines for COVID-19 in a New York City children's hospital. J Pediatr Surg, 2020, 55(8): 1427-1430.
27.	Chawla D, Chirla D, Dalwai S, et al. Perinatal-neonatal management of COVID-19 infection - guidelines of the federation of obstetric and gynecological societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP). Indian Pediatr, 2020, 57(6): 536-548.
28.	Ezenwa BN, Fajolu IB, Akinajo OR, et al. Management of covid-19: a practical guideline for maternal and newborn health care providers in Sub-Saharan Africa. J Matern Fetal Neonatal Med, 2020: 1-7.
29.	Grilli R, Magrini N, Penna A, et al. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet, 2000, 355(9198): 103-106.
30.	Li W, Zhou Q, Tang Y, et al. Protocol for the development of a rapid advice guidelines for management of children with SARS-CoV-2 infection. Ann Palliat Med, 2020, 9(4): 2251-2255.
31.	NICE. COVID-19 rapid guideline: managing COVID-19. London: National Institute for Health and Care Excellence, 2021.
32.	NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence, 2021.
33.	本刊综合. 儿童感染新冠有些什么症状. 人人健康, 2021, (4): 47.

1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard, 2021-11-12. Available at: https: //covid19. who. int/.
2. World Health Organization. WHO Coronavirus (COVID-19) Dashboard, 2021-08-08. Available at: https: //covid19. who. int/.
3. Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med, 2020, 382(17): 1663-1665.
4. Panda PK, Sharawat IK, Natarajan V, et al. COVID-19 treatment in children: A systematic review and meta-analysis. J Family Med Prim Care, 2021, 10(9): 3292-3302.
5. Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ: advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18): E839-E842.
6. Chen Y, Wang C, Shang H, et al. Clinical practice guidelines in China. BMJ, 2018, 360: j5158.
7. Nuckols TK, Anderson L, Popescu I, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med, 2014, 160(1): 38-47.
8. Inaba K. The significant of practical guideline in social context. Clin Neurol, 2003, 43(11): 850-851.
9. Henderson LA, Canna SW, Friedman KG, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol, 2020, 72(11): 1791-1805.
10. Henderson LA, Canna SW, Friedman KG, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol, 2021, 73(4): e13-e29.
11. Karimi M, Bozorgi H, Zarei T, et al. Antithrombotic prophylaxis in children and adolescents' patients with SARS-CoV-2 (COVID-19) infection: A practical guidance for clinicians. Acta Biomed, 2020, 91(4): e2020170.
12. Cattalini M, Taddio A, Bracaglia C, et al. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics. Ital J Pediatr, 2021, 47(1): 24.
13. Wang L, Shi Y, Xiao T, et al. Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition). Ann Transl Med, 2020, 8(3): 47.
14. Matava CT, Kovatsis PG, Lee JK, et al. Pediatric airway management in COVID-19 patients: consensus guidelines from the society for pediatric anesthesia's pediatric difficult intubation collaborative and the Canadian pediatric anesthesia society. Anesth Analg, 2020, 131(1): 61-73.
15. Hennon TR, Penque MD, Abdul-Aziz R, et al. COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) guidelines; a Western New York approach. Prog Pediatr Cardiol, 2020: 101232.
16. Thompson S, Bohn MK, Mancini N, et al. IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients. Clin Chem Lab Med, 2020, 58(12): 2009-2016.
17. Wolf J, Abzug MJ, Wattier RL, et al. Initial guidance on use of monoclonal antibody therapy for treatment of coronavirus disease 2019 in children and adolescents. J Pediatric Infect Dis Soc, 2021, 10(5): 629-634.
18. Edelson DP, Sasson C, Chan PS, et al. Interim guidance for basic and advanced life support in adults, children, and neonates with suspected or confirmed COVID-19: from the emergency cardiovascular care committee and get with the guidelines-resuscitation adult and pediatric task forces of the American Heart Association. Circulation, 2020, 141(25): e933-e943.
19. Ong GY, Ng BHZ, Mok YH, et al. Interim Singapore guidelines for basic and advanced life support for paediatric patients with suspected or confirmed COVID-19. Singapore Med J, 2021, online ahead of print. Doi: 10.11622/smedj.2021014.
20. Chiotos K, Hayes M, Kimberlin DW, et al. Multicenter interim guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2. J Pediatric Infect Dis Soc, 2021, 10(1): 34-48.
21. Bansal N, Azeka E, Neunert C, et al. Multisystem inflammatory syndrome associated with COVID-19 anti-thrombosis guideline of care for children by action. Pediatr Cardiol, 2021, 42(7): 1635-1639.
22. Liu E, Smyth RL, Luo Z, et al. Rapid advice guidelines for management of children with COVID-19. Ann Transl Med, 2020, 8(10): 617.
23. 曾玫, 柳龚堡. 儿童新型冠状病毒感染/肺炎疑似和确诊病例快速筛查和临床实践指南. 中国循证儿科杂志, 2020, 15(1): 1-4.
24. 陈志敏, 傅君芬, 舒强, 等. 儿童2019冠状病毒病(COVID-19)诊疗指南(第二版). 浙江大学学报(医学版), 2020, 49(2): 139-146.
25. Dulek DE, Fuhlbrigge RC, Tribble AC, et al. Multidisciplinary guidance regarding the use of immunomodulatory therapies for acute coronavirus disease 2019 in pediatric patients. J Pediatric Infect Dis Soc, 2020, 9(6): 716-737.
26. DeFazio JR, Kahan A, Fallon EM, et al. Development of pediatric surgical decision-making guidelines for COVID-19 in a New York City children's hospital. J Pediatr Surg, 2020, 55(8): 1427-1430.
27. Chawla D, Chirla D, Dalwai S, et al. Perinatal-neonatal management of COVID-19 infection - guidelines of the federation of obstetric and gynecological societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP). Indian Pediatr, 2020, 57(6): 536-548.
28. Ezenwa BN, Fajolu IB, Akinajo OR, et al. Management of covid-19: a practical guideline for maternal and newborn health care providers in Sub-Saharan Africa. J Matern Fetal Neonatal Med, 2020: 1-7.
29. Grilli R, Magrini N, Penna A, et al. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet, 2000, 355(9198): 103-106.
30. Li W, Zhou Q, Tang Y, et al. Protocol for the development of a rapid advice guidelines for management of children with SARS-CoV-2 infection. Ann Palliat Med, 2020, 9(4): 2251-2255.
31. NICE. COVID-19 rapid guideline: managing COVID-19. London: National Institute for Health and Care Excellence, 2021.
32. NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence, 2021.
33. 本刊综合. 儿童感染新冠有些什么症状. 人人健康, 2021, (4): 47.

Previous Article
Bibliometric analysis of health technology assessment
Next Article
Construction of provincial health emergency team in Sichuan province

Chinese Journal of Evidence-Based Medicine

Quality assessment for pediatric COVID-19 guidelines

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content